Sign in
CompletedPhase 3

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

Key facts

Who runs it
ModernaTX, Inc.
Where
Akron, Anderson, Annapolis, Athens, Austin, Banning, Baton Rouge, Beaumont, Biloxi, Binghamton, Bountiful, Canoga Park, Chamblee, Charlotte, Chicago, Cincinnati, Columbia, Columbus, Covington, Crystal River, Dallas, Decatur, Denver, Elkhorn, Fayetteville, Fort Collins, Fort Worth, Fremont, Gaffney, Glendale, Grand Island, Grants Pass, Greenville, Gulfport, Gurnee, Hendersonville, Hialeah, Holladay, Hollywood, Houston, Huntington Beach, Inverness, Jacksonville, Jupiter, La Mesa, Lake City, Lakeland, Las Vegas, Lenexa, Lincoln, Little Rock, Longmont, Los Angeles, Maitland, McKinney, Medford, Meridian, Metairie, Miami, Miami Lakes, Missoula, Morehead City, Myrtle Beach, New Orleans, Newton, Norcross, Norfolk, North Las Vegas, Oklahoma City, Omaha, Palmetto Bay, Phoenix, Plano, Pomona, Portsmouth, Raleigh, Rapid City, Red Oak, Richmond, River Forest, Riverside, Rochester, Rockville, Rolling Hills Estates, Salt Lake City, San Antonio, San Diego, San Francisco, San Ramon, Sandy Springs, Savannah, Sioux City, South Ogden, Southfield, Spartanburg, Springfield, St Louis, Stockbridge, Suffolk, Sugar Land, Syracuse, Tampa, Tempe, Tucson, Tulsa, Valparaiso, Warwick, West Jordan, Wichita, Wilmington, Winston-Salem, and Yukon, United StatesSee the 133 sitesAlso in 10 other countries, 98 sites
Status
Completed
Phase
Phase 3
People taking part
22,502 people enrolled
Started
14 Sept 2022
Ended
5 Jan 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • mRNA-1010
  • Fluarix Quadrivalent
Record updated
16 January 2025

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Investigator has assessed that the participant understands and is willing and physically able to comply with protocol mandated follow-up, including all procedures; For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first dose on Day 1, and agreement to continue adequate contraception through 90 days following vaccine administration

Who cannot take part

  • Participant has had close contact to someone with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or COVID-19 as defined by the US CDC or has had a positive SARS-CoV-2 test in the past 10 days prior to the Screening visit
  • Participant is acutely ill or febrile (temperature ≥38.0℃elcius [100.4°Fahrenheit]) 72 hours prior to or at the Screening visit or Day 1. Participants meeting this criterion may be rescheduled within the 28-day screening window
  • Participant has received systemic immunosuppressant drugs for >14 days in total within 180 days prior to the Screening visit (for glucocorticosteroids, ≥10 milligrams (mg)/day of prednisone or equivalent) or is anticipating the need for systemic immunosuppressive treatment at any time during participation in the study. Inhaled, nasal, and topical steroids are allowed
  • Participant has received any vaccine authorized or approved by local health agency ≤28 days prior to study intervention (Day 1) or plans to receive a vaccine authorized or approved by local health agency within 28 days before or after the study intervention
  • Participant is unaware whether they have received an influenza vaccine in the previous influenza season
  • Participant received a seasonal influenza vaccine or any other investigational influenza vaccine within 180 days prior to Day 1
  • Participant has tested positive for influenza by local health authority-approved testing methods within 180 days prior to Day 1
  • Participant has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening visit or plans to donate blood products during the study; Note: Other inclusion and exclusion criteria may apply
  • Participant has a history of a diagnosis or condition that, in the judgment of the investigator, is clinically unstable or may affect participant safety, assessment of safety endpoints, assessment of immune response, or adherence to study procedures
  • Reported history of congenital or acquired immunodeficiency, immunocompromising/ immunosuppressive condition, asplenia, or recurrent severe infections
  • Reported history of anaphylaxis or severe hypersensitivity reaction after receipt of any mRNA or influenza vaccines or any components of the mRNA or influenza vaccines, including egg protein
  • Participant has had close contact with someone with laboratory-confirmed influenza infection or with someone who has been treated with antiviral therapies for influenza (for example, Tamiflu®) within the past 5 days prior to the Screening visit

Where in United States

Also in 10 other countries, 98 sites

  • Radiant ResearchAkron, United States
  • Velocity Clinical Research, GreenvilleAnderson, United States
  • Privia Medical GroupAnnapolis, United States
  • North Alabama Research Center LLCAthens, United States
  • Tekton Research, IncAustin, United States
  • Velocity Clinical Research - BanningBanning, United States
  • Meridian Clinical ResearchBaton Rouge, United States
  • Platinum Research Network, LLCBeaumont, United States
  • Paul G Matherne MDBiloxi, United States
  • United Medical AssociatesBinghamton, United States
  • Cope Family MedicineBountiful, United States
  • Hope Clinical Research, LLCCanoga Park, United States
  • Tekton Research, Inc.Chamblee, United States
  • Tryon Medical GroupCharlotte, United States
  • Great Lakes Clinical Trials LLCChicago, United States
  • CTI Clinical Research CenterCincinnati, United States
  • Sterling Research GroupCincinnati, United States
  • Velocity Clinical Research - CincinnatiCincinnati, United States
  • Velocity Clinical Research, ColumbiaColumbia, United States
  • Southeast Regional Research GroupColumbus, United States
  • MedPharmicsCovington, United States
  • Nature Coast Clinical Research, LLC - Crystal RiverCrystal River, United States
  • Zenos Clinical ResearchDallas, United States
  • iResearch Atlanta, LLCDecatur, United States
  • Velocity Clinical Research, DenverDenver, United States
  • CCT Research at Skyline Medical Center, PCElkhorn, United States
  • Carolina Institute For Clinical ResearchFayetteville, United States
  • Arthritis & Rheumatology - Clinic of Northern ColoradoFort Collins, United States
  • Benchmark ResearchFort Worth, United States
  • CCT Research / Methodist Physicians Clinic, Prairie Fields Family Medicine, PCFremont, United States
  • Velocity Clinical Research, GaffneyGaffney, United States
  • Lenzmeier Family MedicineGlendale, United States
  • Meridian Clinical ResearchGrand Island, United States
  • Velocity Clinical Research, Grants PassGrants Pass, United States
  • Velocity Clinical Research - GreenvilleGreenville, United States
  • DelRicht Research at Gulfport MemorialGulfport, United States
  • Great Lakes Clinical Trials LLCGurnee, United States
  • DelRicht ResearchHendersonville, United States
  • Floridian Clinical ResearchHialeah, United States
  • Homestead Associates in Research,IncHialeah, United States
  • Olympus Family Medicine/CCT ResearchHolladay, United States
  • Broward Research GroupHollywood, United States
  • DM Clinical ResearchHouston, United States
  • Texas Center for Drug Development, Inc.Houston, United States
  • Marvel Clinical ResearchHuntington Beach, United States
  • Citrus Cardiology ConsultantsInverness, United States
  • Encore Research Group-Jacksonville Center for Clinical ReseaJacksonville, United States
  • Health Awareness, IncJupiter, United States
  • Velocity Clinical Research Chula VistaLa Mesa, United States
  • Velocity Clinical Research, San DiegoLa Mesa, United States
  • Multi-Therapeutic Research Associates, Inc.Lake City, United States
  • Accel Research Sites LakelandLakeland, United States
  • CCT ResearchLas Vegas, United States
  • Clinical Research Center of Nevada LLCLas Vegas, United States
  • Santa Rosa Medical Centers of Nevada/ CCT ResearchLas Vegas, United States
  • Johnson County Clin-Trials (JCCT)Lenexa, United States
  • Be Well Clinical Studies LLCLincoln, United States
  • Baptist Health Center for Clinical ResearchLittle Rock, United States
  • Lynn Institute of the OzarksLittle Rock, United States
  • Longmont Medical Research NetworkLongmont, United States
  • Velocity Clinical Research, WestlakeLos Angeles, United States
  • ARS - Meridien ResearchMaitland, United States
  • DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINEMcKinney, United States
  • Velocity Clinical Resarch - MedfordMedford, United States
  • Velocity Clinical Research, BoiseMeridian, United States
  • MedPharmics, LLCMetairie, United States
  • Clinical Trials of Florida, LLCMiami, United States
  • Miami centre of clinical researchMiami, United States
  • South Florida Research Center, Inc.Miami, United States
  • Suncoast Research Associates Trials, LLCMiami, United States
  • Global Health Research CenterMiami Lakes, United States
  • Montana Medical Research, IncMissoula, United States
  • Diabetes & Endocrinology ConsultantsMorehead City, United States
  • Carolina Health SpecialistsMyrtle Beach, United States
  • Nathan H Fischman MD LLCNew Orleans, United States
  • Heartland Research Associates, LLCNewton, United States
  • In-Quest Medical ResearchNorcross, United States
  • Medpace, Inc. - Clinical Pharmacology Unit (CPU)Norfolk, United States
  • Meridian Clinical ResearchNorfolk, United States
  • Las Vegas Clinical Trials, LLCNorth Las Vegas, United States
  • Lynn Health Science InstituteOklahoma City, United States
  • Meridian Clinical Research - OmahaOmaha, United States
  • Midwest Regional Health Services, LLC/CCT ResearchOmaha, United States
  • Papillon Research CentreOmaha, United States
  • Innovation Medical Research Center, IncPalmetto Bay, United States
  • CCT ResearchPhoenix, United States
  • Research Your HealthPlano, United States
  • Empire Clinical ResearchPomona, United States
  • Meridian Clinical ResearchPortsmouth, United States
  • M3 Wake Research, Inc.Raleigh, United States
  • Black Hills Center for American Indian HealthRapid City, United States
  • Epic Medical Research, LLCRed Oak, United States
  • Clinical Research Partners, LLCRichmond, United States
  • Chicago Health Medical GroupRiver Forest, United States
  • Artemis Institute for Clinical ResearchRiverside, United States
  • Benchmark Research-TexasRiverside, United States
  • Rochester Clinical Research, IncRochester, United States
  • Rockville Internal Medicine GroupRockville, United States
  • Peninsula Research Associates PraRolling Hills Estates, United States
  • CenExel - JBRSalt Lake City, United States
  • Clinical Trials of Texas IncSan Antonio, United States
  • Acclaim Clinical ResearchSan Diego, United States
  • Artemis Institute for Clinical ResearchSan Diego, United States
  • Medical Center for Clinical ResearchSan Diego, United States
  • Women's Health Care Research Corp.San Diego, United States
  • Shawn K Hassler MDSan Francisco, United States
  • West Coast Research LLCSan Ramon, United States
  • Mount Vernon Clinical ResearchSandy Springs, United States
  • Meridian Clinical Research - SavannahSavannah, United States
  • Meridian Clinical Research - Dakota DunesSioux City, United States
  • South Ogden Family Medicine clinic/CCTSouth Ogden, United States
  • DM Clinical Research - DetroitSouthfield, United States
  • Spartanburg Regional Health ServicesSpartanburg, United States
  • DelRicht ResearchSpringfield, United States
  • National Medical University and Embryonic Tissues Center EmCSpringfield, United States
  • Sundance Clinical Research, LLCSt Louis, United States
  • Clinical Research AtlantaStockbridge, United States
  • Lakeview Medical CenterSuffolk, United States
  • Breco Research - A Tarheel Clinical Research SiteSugar Land, United States
  • DM Clinical ResearchSugar Land, United States
  • Velocity Clinical Research - SyracuseSyracuse, United States
  • New Tampa Health, IncTampa, United States
  • Fiel Family and Sports Medicine/CCT ResearchTempe, United States
  • Noble Clinical ResearchTucson, United States
  • DelRicht Research - TulsaTulsa, United States
  • Velocity Clinical Research, ValparaisoValparaiso, United States
  • Velocity Clinical Research ProvidenceWarwick, United States
  • Velocity Clinical Research, Salt Lake CityWest Jordan, United States
  • Alliance for Multispecialty ResearchWichita, United States
  • PMG Research of WilmingtonWilmington, United States
  • Trial Management AssociatesWilmington, United States
  • Wake Forest Baptist Medical CenterWinston-Salem, United States
  • Platinum Research Network, LLCYukon, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and efficacy of mRNA-1010 in preventing seasonal influenza in adults 50 years and older.

The 2 groups in the trial

  • mRNA-1010Treatment being tested

    Participants will receive a single dose of mRNA-1010 by intramuscular (IM) injection on Day 1.

  • Fluarix QuadrivalentExisting treatment, for comparison

    Participants will receive a single dose of Fluarix Quadrivalent by IM injection on Day 1.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older
Publications
Record updated
16 January 2025